ILSI North America, 740 15th Street, NW, Suite 600, Washington, DC, 20005, USA.
National Exposure Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, USA.
Food Chem Toxicol. 2019 Dec;134:110819. doi: 10.1016/j.fct.2019.110819. Epub 2019 Sep 20.
Programs including the ToxCast project have generated large amounts of in vitro high‒throughput screening (HTS) data, and best approaches for the interpretation and use of HTS data, including for chemical safety assessment, remain to be evaluated. To fill this gap, we conducted case studies of two indirect food additive chemicals where ToxCast data were compared with in vivo toxicity data using the RISK21 approach. Two food contact substances, sodium (2-pyridylthio)-N-oxide and dibutyltin dichloride, were selected, and available exposure data, toxicity data, and model predictions were compiled and assessed. Oral equivalent doses for the ToxCast bioactivity data were determined by in-vitro in-vivo extrapolation (IVIVE). For sodium (2-pyridylthio)-N-oxide, bioactive concentrations in ToxCast assays corresponded to low- and no-observed adverse effect levels in animal studies. For dibutyltin dichloride, the ToxCast bioactive concentrations were below the dose range that demonstrated toxicity in animals; however, this was confounded by the lack of toxicokinetic data, necessitating the use of conservative toxicokinetic parameter estimates for IVIVE calculations. This study highlights the potential utility of the RISK21 approach for interpretation of the ToxCast HTS data, as well as the challenges involved in integrating in vitro HTS data into safety assessments.
项目包括 ToxCast 项目已经产生了大量的体外高通量筛选(HTS)数据,而解释和使用 HTS 数据的最佳方法,包括化学安全评估,仍有待评估。为了填补这一空白,我们对两种间接食品添加剂化学品进行了案例研究,使用 RISK21 方法比较了 ToxCast 数据和体内毒性数据。选择了两种食品接触物质,即吡啶硫代-N-氧化物和二丁基锡二氯化物,并编制和评估了可用的暴露数据、毒性数据和模型预测。通过体外-体内外推法(IVIVE)确定了 ToxCast 生物活性数据的口服等效剂量。对于吡啶硫代-N-氧化物,ToxCast 测定中的生物活性浓度与动物研究中的低观察不良效应水平和无观察不良效应水平相对应。对于二丁基锡二氯化物,ToxCast 的生物活性浓度低于在动物中表现出毒性的剂量范围;然而,由于缺乏毒代动力学数据,需要使用保守的毒代动力学参数估计值进行 IVIVE 计算,这使得情况变得复杂。本研究强调了 RISK21 方法在解释 ToxCast HTS 数据方面的潜在效用,以及将体外 HTS 数据纳入安全评估所涉及的挑战。